The Fitzpatrick Lab specializes in biomaterials and regenerative medicine, with a strong emphasis on biomaterial host responses, inflammation and wound healing, and Type 1 diabetes. Our research efforts are focused on two major themes: (1) elucidating signaling pathways that induce an inflammatory response in responding innate immune cells, and (2) developing in vitro human biomaterial host response models for biomaterials development. We are currently applying these themes to explore mechanisms of host responses to implants and devices used to manage type 1 diabetes, in particular insulin infusion sets.
Fitzpatrick Lab 2024/25: (L-R): Skylar, Meghan, Kathryn, Thamali, Fredrick, Yuxi and Lindsay.
